As HIV has a high seroprevalence in Sub-Saharan Africa, most primary care providers will recognise a patient with advanced disease quite readily and offer voluntary counselling and testing (VCT) to confirm the suspected diagnosis of HIV infection. Modern antiretroviral therapy (ART) results in decreased opportunistic infections, increased disease free time survival and decreased mortality. 1, 2 However, patients with early disease do not present with the same features seen in advanced disease. It is also, however, of the utmost importance to also diagnose HIV infection in these individuals. Firstly, the infected person can take steps so as not to infect others, and secondly, steps may be taken to preserve the immune status for as long as possible so as to delay the initiation of ART. The diagnosis of HIV infection begins with the recognition and identification of people at risk of infection (see Table 1 ). Many people with HIV infection are asymptomatic when they first visit a clinician. In such cases it is particularly important for the clinician to be proactive in obtaining the information required to make a valid assessment of the risk of HIV infection. This assessment should be based on knowledge of the local community as well as individual living circumstances, lifestyle information where it is pertinent, and clinical observations. For patients who do not display overt symptoms or signs of HIV infection, the physician needs to have a high index of suspicion and, in addition, needs to take a careful history and obtain information pertinent to the present and past medical history, including family history, and the social and vocational circumstances of the patient.
The majority of people in Africa with HIV infection present with symptoms when they first visit a clinician. Among these, some will be exhibiting signs and symptoms of acute infection, but most will have advanced immuno-deficiency. In such cases it is particularly important for the clinician to realise that the patient does not necessarily know the cause of his or her symptoms. Even when lifestyle information, reported symptoms, clinical observations and knowledge of the local community all strongly suggest a diagnosis of HIV infection, other potential diagnoses should not be disregarded, especially if these are more easily treated or likely to cause less distress to the patient.
The all-so-important question that needs to be considered is who should be hiv/aids hiv/aids offered VCT and when should a patient be tested for HIV (see Table 2 ).
The first consultation
The first meeting between the HIVinfected person and the healthcare provider is of utmost importance because it establishes a relationship and, hopefully, partnership that may last for many years. It should therefore be regarded as an opportunity to begin developing a mutually beneficial relationship as well as an opportunity to collect clinical information. The initial assessment of the HIV-infected person should include: (i) a comprehensive clinical history, (ii) a thorough physical examination and (iii) the taking of samples for laboratory tests to provide information that enables the clinician to: Continued on p6 ➦ 
Laboratory diagnosis of HIV infection
In South Africa, serological testing for anti-HIV antibodies is currently recommended for the diagnosis of HIV infection. 3, 4 Although the diagnosis of HIV can also be made by the detection of viral antigens such as p24 (the core protein of the virus), the detection of viral nucleic acid by polymerase chain reaction (PCR), or by isolating the virus in cell (lymphocyte) culture, assays based on the detection of antibodies to the antigens of HIV are most commonly used in the form of Enzyme Linked Immunosorbent Assay (ELISA). 3, 4 In areas with a high seroprevalence of HIV infection (prevalence > 5%), the Global Programme on AIDS of the World Health Organisation suggests that multiple ELISA's can be used to accurately determine the HIV status of an individual. Most rapid tests are applications of the ELISA principle, and some of the rapid tests are highly respected and feature amongst the top bench ELISA's in their accuracy. According to WHO guidelines, on site testing can be done using two different types of rapid tests. The blood is obtained through a finger prick. On site testing has the advantage of a quick turn around time for results and the patient can be given his/her result almost immediately. This may be particularly useful in a group of patients who may not return for their results. Pre-test counselling is regarded as a prerequisite to performing an HIV test, including rapid tests. The patient must give his/her response to the test and persons doing the test without the patient's consent are liable for prosecution. 5 Whilst multiple ELISA testing has been used in developing countries (including South Africa), the most widely used confirmatory test for HIV infection in most developed countries is a qualitative HIV DNA polymerase chain reaction (PCR) for detection of viral particles in the plasma or the Western blot test.
( Table 3 .) The Western blot assay is very labour intensive, relatively expensive and sometimes gives indeterminate results. 3, 4 The HIV DNA polymerase chain reaction test is a qualitative molecular assay that determines whether HIV is present in the blood. It is reported as positive or negative and needs to be distinguished from quantitative HIV RNA PCR assays that determine the viral load (amount of HIV RNA in the blood) and is expressed as the number of HIV RNA copies per millilitre (RNA copies/ml) or the logarithmic equivalent -log10 equivalent. 6
Window period
Tests detecting the actual viral particle will become positive before the antibody response due to the virus appearing in the peripheral blood in its early replication cycles (viraemia) before serocoversion occurs. In this phase of infection, the levels of virus detectable (the viral load) may be very high. Current experience puts the antibody window period utilising the latest generations of antibody tests in most (but not all) cases at about 21-24 days and this is compatible with our understanding of the pathogenesis of generalised viral infections. After the immune system responds, the viral load typically drops considerably to reach a steady state (the set point) and will remain at this level characteristic for a given individual for a number of years.
Insurance testing
In situations where healthy individuals are screened, such as in insurance testing, the pre-test likelihood may be much less predictable because of the clustering of groups with different HIV prevalence. Confirmatory testing assumes more importance and there are typically protocols in place to handle insurance testing. However, the direct involvement of a knowledgeable clinician in cases where false positive results have emerged would considerably ameliorate the associated difficulties and suffering.
Special considerations in the newborn
Infants born to HIV-infected women can test positive in serological (antibody) tests for HIV up to 18 months following birth, due to the transfer of maternal antibodies across the placenta. Beyond this age, however, only truly HIV-infected children test positive for HIV in ELISA and Western blot assays. In the absence of hypogammaglobulinemia, infants who revert to being negative for HIV antibodies after 12 months of age are not infected with HIV.
Most HIV-infected infants can be diagnosed during the first month of life, often before the development of any HIV-related symptoms. 7 The most important laboratory investigation for this is PCR to detect HIV DNA in peripheral blood mononuclear cells. Due to the risk of contamination with maternal blood, infant blood samples taken for diagnostic evaluation should not be collected from the umbilical cord blood and furthermore, the sensitivity of PCR is not good in the first week of life. This is probably a reflection of the importance of perinatal transmission as the main means by which an infant acquires infection. An infant born to an HIVinfected mother is considered uninfected if PCR results are persistently negative until > 4 months of age in the absence of breastfeeding. 7
Tests for additional clinical information
Several laboratory tests should be performed in patients with serologically confirmed HIV infection. These include quantitative HIV RNA measurement (how actively is the virus replicating?), CD4+ cell count (how far is the immune system compromised?), complete blood count and chemistry, tests for certain sexually transmitted diseases (RPR) as well as other infectious diseases. False-positive tests for syphilis are common, but can be excluded by use of a confirmatory FTA test.
Appropriate gynaecological tests (cervical smear) are also useful for female patients. It is, however, important to approach all aspects of management with a view to optimising the outcome for the patient including the costs. The decision to implement antiretroviral treatment requires a comprehensive view including the all-important assessment of the adherence profile of a given patient.
Evaluating the degree of immune dysfunction
HIV causes gradual but progressive immunodeficiency and measurement of the immune status of the patient has become central to HIV management. The most important cell involved in the immune attrition is the CD4+ Tlymphocyte as it has a co-ordinating and central role in the immune response. 8 Derangements occur involving other components of the immune system, both humoral and cellular, but the level of CD4+ cells in the peripheral blood is the key parameter to use in monitoring the changes. It has an invaluable role in staging HIV infection, establishing the risk of specific HIVassociated complications, determining the need for prophylaxis against opportunistic infections and assessing responses to antiretroviral therapy. In adolescents and adults, normal CD4+ cell counts vary between 700 and 1100 cells per microlitre (μl) blood. In HIV infected adults, CD4+ counts will usually fall by 40-80 cells/μl/year. The CD4+ cell count is a relatively good surrogate marker for immune function as presented in Table 4 . In infants and children, CD4+ cell numbers may exceed 2000 cells/μl and are likely to fall much more rapidly due to the higher viral load in children who have a less developed immune system, which is less effective in combating HIV. In children, CD4+ cell counts are usually expressed as a percentage of the lymphocyte count (CD4%). The CD4% is less subject to variation on repeated measures.
Full blood count and serum chemistry
A complete blood count should be obtained to check for anaemia, leukopenia and thrombocytopenia, which are all common in HIV-infected individuals, to facilitate calculation of the absolute CD4+ cell count and to provide baseline data prior to the initiation of potentially myelo-suppressive therapy. Blood chemistry should also be assessed to provide information on the patient's nutritional status, renal function and hepatic function (transaminases), and to provide baseline data prior to the initiation of potentially hepatotoxic therapy. In patients who have deranged liver function tests, further tests should be considered to exclude hepatitis B and hepatitis C.
Follow-up visits
Follow-up has to be arranged to discuss the results and plan the further management of the patient. The diagnosis of HIV impacts not only on the infected individual, but has far reaching consequences for his/her family, partner and friends. The patient needs to receive as much relevant information as possible about the condition, but also a supportive environment in which a doctor-patient partnership can grow. The counselling process is ongoing, there are no quick answers and the physician must assist his/her patient to develop coping skills. 9, 10 
